1617 related articles for article (PubMed ID: 18992950)
41. Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.
Parhar PK; Duckworth T; Shah P; DeWyngaert JK; Narayana A; Formenti SC; Shah JN
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):379-84. PubMed ID: 20015598
[TBL] [Abstract][Full Text] [Related]
42. Accelerated partial breast irradiation (APBI): are breath-hold and volumetric radiation therapy techniques useful?
Essers M; Osman SO; Hol S; Donkers T; Poortmans PM
Acta Oncol; 2014 Jun; 53(6):788-94. PubMed ID: 24689645
[TBL] [Abstract][Full Text] [Related]
43. Dosimetric comparison of postoperative whole pelvic radiotherapy for endometrial cancer using three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy.
Yang R; Xu S; Jiang W; Wang J; Xie C
Acta Oncol; 2010; 49(2):230-6. PubMed ID: 20001497
[TBL] [Abstract][Full Text] [Related]
44. Can protons improve SBRT for lung lesions? Dosimetric considerations.
Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous integrated boost in breast conserving treatment of breast cancer: a dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy.
Hijal T; Fournier-Bidoz N; Castro-Pena P; Kirova YM; Zefkili S; Bollet MA; Dendale R; Campana F; Fourquet A
Radiother Oncol; 2010 Mar; 94(3):300-6. PubMed ID: 20171752
[TBL] [Abstract][Full Text] [Related]
46. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
47. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
48. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B
Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823
[TBL] [Abstract][Full Text] [Related]
49. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
Smeenk RJ; van Lin EN; van Kollenburg P; Kunze-Busch M; Kaanders JH
Radiother Oncol; 2009 Oct; 93(1):131-6. PubMed ID: 19523704
[TBL] [Abstract][Full Text] [Related]
50. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
51. Clinical dosimetric study of three radiotherapy techniques for postoperative breast cancer: Helical Tomotherapy, IMRT, and 3D-CRT.
Zhou GX; Xu SP; Dai XK; Ju ZJ; Gong HS; Xie CB; Yin LM; Yang J
Technol Cancer Res Treat; 2011 Feb; 10(1):15-23. PubMed ID: 21214284
[TBL] [Abstract][Full Text] [Related]
52. Helical tomotherapy-based STAT RT: Dosimetric evaluation for clinical implementation of a rapid radiation palliation program.
McIntosh A; Dunlap N; Sheng K; Geezey C; Turner B; Blackhall L; Weiss G; Lappinen E; Larner JM; Read PW
Med Dosim; 2010; 35(4):280-6. PubMed ID: 19944589
[TBL] [Abstract][Full Text] [Related]
53. Major reduction of monitor units with the avoidance of leaf-sequencing step by direct aperture based IMRT optimisation.
Seppälä J; Lahtinen T; Kolmonen P
Acta Oncol; 2009; 48(3):426-30. PubMed ID: 18766997
[TBL] [Abstract][Full Text] [Related]
54. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.
Sterzing F; Schubert K; Sroka-Perez G; Kalz J; Debus J; Herfarth K
Strahlenther Onkol; 2008 Jan; 184(1):8-14. PubMed ID: 18188517
[TBL] [Abstract][Full Text] [Related]
55. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.
Johansson J; Blomquist E; Montelius A; Isacsson U; Glimelius B
Radiother Oncol; 2004 Aug; 72(2):129-38. PubMed ID: 15297132
[TBL] [Abstract][Full Text] [Related]
56. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality.
Lohr F; El-Haddad M; Dobler B; Grau R; Wertz HJ; Kraus-Tiefenbacher U; Steil V; Madyan YA; Wenz F
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):73-80. PubMed ID: 18973977
[TBL] [Abstract][Full Text] [Related]
57. Impact of increasing margin around the lumpectomy cavity to define the planning target volume for 3D conformal external beam accelerated partial breast irradiation.
Cox BW; Horst KC; Thornton S; Dirbas FM
Med Dosim; 2007; 32(4):254-62. PubMed ID: 17980825
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric comparisons of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy in whole abdominopelvic radiotherapy for gynecologic malignancy.
Kim YB; Kim JH; Jeong KK; Seong J; Suh CO; Kim GE
Technol Cancer Res Treat; 2009 Oct; 8(5):369-77. PubMed ID: 19754213
[TBL] [Abstract][Full Text] [Related]
59. Dosimetric comparison of conventional and forward-planned intensity-modulated techniques for comprehensive locoregional irradiation of post-mastectomy left breast cancers.
Cavey ML; Bayouth JE; Endres EJ; Pena JM; Colman M; Hatch S
Med Dosim; 2005; 30(2):107-16. PubMed ID: 15922178
[TBL] [Abstract][Full Text] [Related]
60. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
